United Pharm (033270) — Net Asset Quality Index
United Pharm (033270) has a Net Asset Quality Index of 87.5% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩519.49 Billion minus total liabilities of ₩64.86 Billion yields net assets of ₩454.63 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 033270 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
United Pharm Net Asset Quality Index Over Time (2011–2025)
This chart shows how United Pharm's Net Asset Quality Index has evolved across 14 annual periods from 2011 to 2025. As of December 2025, the index stands at 87.5%, representing net assets of ₩454.63 Billion against total assets of ₩519.49 Billion KRW. See 033270 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for United Pharm (2011–2025)
The table below presents the year-by-year Net Asset Quality Index for United Pharm from 2011 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see United Pharm market capitalisation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 87.5% | ₩454.63 Billion | ₩519.49 Billion | ₩64.86 Billion | ▲ +1.8 pp |
| 2024 | 85.7% | ₩406.21 Billion | ₩473.93 Billion | ₩67.72 Billion | ▲ +4.9 pp |
| 2023 | 80.8% | ₩378.68 Billion | ₩468.86 Billion | ₩90.18 Billion | ▼ -0.1 pp |
| 2022 | 80.8% | ₩337.86 Billion | ₩417.89 Billion | ₩80.03 Billion | ▲ +1.7 pp |
| 2021 | 79.1% | ₩300.71 Billion | ₩380.03 Billion | ₩79.32 Billion | ▲ +0.8 pp |
| 2020 | 78.3% | ₩276.89 Billion | ₩353.43 Billion | ₩76.54 Billion | ▲ +1.3 pp |
| 2019 | 77.0% | ₩255.10 Billion | ₩331.24 Billion | ₩76.14 Billion | ▲ +1.3 pp |
| 2018 | 75.7% | ₩228.48 Billion | ₩301.95 Billion | ₩73.47 Billion | ▼ -0.2 pp |
| 2017 | 75.9% | ₩201.68 Billion | ₩265.80 Billion | ₩64.11 Billion | ▲ +0.1 pp |
| 2016 | 75.7% | ₩177.39 Billion | ₩234.22 Billion | ₩56.83 Billion | ▲ +1.2 pp |
| 2014 | 74.5% | ₩161.83 Billion | ₩217.10 Billion | ₩55.27 Billion | ▲ +1.5 pp |
| 2013 | 73.1% | ₩141.44 Billion | ₩193.54 Billion | ₩52.10 Billion | ▲ +1.9 pp |
| 2012 | 71.2% | ₩133.48 Billion | ₩187.58 Billion | ₩54.10 Billion | ▲ +4.7 pp |
| 2011 | 66.5% | ₩113.04 Billion | ₩170.09 Billion | ₩57.04 Billion | — |